These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29948647)

  • 1. The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.
    Redfern AD; Spalding LJ; Thompson EW
    Clin Exp Metastasis; 2018 Apr; 35(4):285-308. PubMed ID: 29948647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y; Lamouille S; Derynck R
    Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
    Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
    Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.
    Chui MH
    Int J Cancer; 2013 Apr; 132(7):1487-95. PubMed ID: 22833228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
    Lee GA; Hwang KA; Choi KC
    Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition in carcinomas of the female genital tract.
    Stewart CJ; McCluggage WG
    Histopathology; 2013 Jan; 62(1):31-43. PubMed ID: 23240668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
    Huang R; Zong X
    Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression.
    Greening DW; Gopal SK; Mathias RA; Liu L; Sheng J; Zhu HJ; Simpson RJ
    Semin Cell Dev Biol; 2015 Apr; 40():60-71. PubMed ID: 25721809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
    Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
    Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting EMT in cancer: opportunities for pharmacological intervention.
    Davis FM; Stewart TA; Thompson EW; Monteith GR
    Trends Pharmacol Sci; 2014 Sep; 35(9):479-88. PubMed ID: 25042456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis.
    Xu Q; Deng F; Qin Y; Zhao Z; Wu Z; Xing Z; Ji A; Wang QJ
    Cell Death Dis; 2016 Jun; 7(6):e2254. PubMed ID: 27277676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
    Lee HM; Hwang KA; Choi KC
    Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
    Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
    Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target.
    Jonckheere S; Adams J; De Groote D; Campbell K; Berx G; Goossens S
    Cells Tissues Organs; 2022; 211(2):157-182. PubMed ID: 33401271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
    Ginnebaugh KR; Ahmad A; Sarkar FH
    Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.